MCAD

NASDAQ

Mountain Crest Acquisition Corp. II

$10.38-0.48 (-4.42%)

News25/Ratings1

Mountain Crest Acquisition Corp. II. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Latest news

25 items

1629d13D/G
SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II
SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)
1629d13D/G
SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II
SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)
1629d13D/G
SEC Form SC 13G filed by Mountain Crest Acquisition Corp. II
SC 13G - Better Therapeutics, Inc. (0001832415) (Subject)
1634dSEC
Mountain Crest Acquisition Corp. II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status
8-K - Better Therapeutics, Inc. (0001832415) (Filer)
1636dINSIDER
SEC Form 3: New insider Heinen Mark claimed ownership of 6,667 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 4: Perry David P bought $2,512,432 worth of shares (251,536 units at $9.99) and was granted 10,578,501 shares
4 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3: New insider Parker Geoffrey M. claimed ownership of 33,333 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 4: Heinen Mark was granted 6,667 shares, increasing direct ownership by 25% to 33,333 units
4 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 4: Parker Geoffrey M. was granted 33,333 shares
4 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 4: Liu Suying acquired 1,402,500 shares
4 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 4 filed by Lavizzo-Mourey Risa J
4 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3: New insider Perry David P claimed ownership of 10,830,037 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3: New insider Wynholds Kristin claimed ownership of 90,015 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3 filed by new insider Zamirowski Justin
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 4: Armanino Andrew J. was granted 61,662 shares
4 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3: New insider Armanino Andrew J. claimed ownership of 61,662 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3: New insider Carmona Richard H claimed ownership of 153,619 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3: New insider Appelbaum Kevin J claimed ownership of 2,406,719 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 4: Carmona Richard H was granted 153,619 shares
4 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3: New insider Berman Mark A. claimed ownership of 231,939 shares
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1636dINSIDER
SEC Form 3 filed by new insider Lavizzo-Mourey Risa J
3 - Better Therapeutics, Inc. (0001832415) (Issuer)
1639d13D/G
SEC Form SC 13G/A filed by Mountain Crest Acquisition Corp. II (Amendment)
SC 13G/A - Better Therapeutics, Inc. (0001832415) (Subject)
1639dPR
Better Therapeutics Closes Business Combination and Debuts on Nasdaq
Trading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTX Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly traded special purpose acquisition corporation or SPAC. The resulting combined company will commence trading its shares on Nasdaq under the ticker symbol "BTTX" on October 29, 2021. The shareholders of Mountain Crest Acquisition Corp II approved the transaction at a special meeting held on October
1640dSEC
SEC Form 25-NSE filed by Mountain Crest Acquisition Corp. II
25-NSE - Mountain Crest Acquisition Corp II (0001832415) (Subject)
1641dSEC
SEC Form 425 filed by Mountain Crest Acquisition Corp. II
425 - Mountain Crest Acquisition Corp II (0001832415) (Subject)